** H-shares of WuXi AppTec rise 6.4% to HK$56.10, the highest since Oct. 10
** Stock third-biggest pct gainer on Hang Seng Index and fourth-biggest on Hang Seng Commerce & Industry Index
, which are up 0.6% and 0.9%, respectively
** Chinese new drug research and development group posts 17% fall in Q3 net profit, 1.96% decline in revenue
** Jefferies maintains "buy", saying Q3 results in-line with expectations and market consensus
** Sees accelerating growth for total backlog, indicating stronger revenue momentum ahead
** Co's Shanghai-listed stock up 5.1% to 56.15 yuan
** Hong Kong stock down 31.2% YTD
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。